Traditional Admission

Apply using AMCASHow to Use AMCAS

Important Dates (2026-2027)

August 1

Early Decision plan primary application (AMCAS) deadline

July 31

Supplemental application invitations begin for both Early Decision and Regular Decision plans on or about July 31st

August 28

Early Decision plan supplemental application deadline

October 1

Early Decision plan admission notification

November 1

Regular Decision plan primary application (AMCAS) deadline

December 1

Regular Decision plan supplemental application deadline

January-July

Regular Decision admission rolling notifications

May 21

AMCAS Choose Your Medical School Tool “Commit to Enroll” to NEOMED deadline

Early and Regular Decision Admission

For candidates applying through AMCAS for M.D. admission:

• Early Decision
• Regular Decision
• M.D. / Ph.D.

Apply to medical school at NEOMED as a college graduate

The College of Medicine at NEOMED welcomes new students via early decision and regular decision admission plans outside of early assurance.

Candidates applying to NEOMED as first-year medicine students apply through the American Medical College Application Service (AMCAS).

As a member of the American Association of Medical Colleges (AAMC), NEOMED participates in a common application service and abides by AAMC deadlines and practices.

EARLY DECISION ADMISSION PLAN

All applicants to the M.D. program who consider NEOMED their medical school of choice and are strongly aligned with its mission are encouraged to apply electing the Early Decision Plan (EDP).

• Early Decision is binding, which means that candidates who receive offers of admission are obligated by AMCAS policy to attend NEOMED should they wish to attend any allopathic school of medicine.
• All Early Decision applicants must present valid MCAT scores, apply through AMCAS by August 1, and have the secondary application (by invitation only) complete and verified to the Office of Admissions by August 28 of the year before anticipated enrollment.
• Notification to the applicant regarding admission is given by October 1. If selected, an EDP admit receives the benefit of early notification of acceptance and is, therefore, obligated to attend the NEOMED College of Medicine under American Association of Medical Colleges (AAMC) admission policy. If not selected for admission through the early decision plan, applicants may then apply to other medical schools. For more about consideration of whether the early decision program is right for you, visit students-residents.aamc.org.

REGULAR  DECISION ADMISSION PLAN

Applicants to the M.D. program who wish to apply to NEOMED and other medical schools in a competitive admission process are encouraged to apply electing the Regular Decision Plan (RDP).

• Regular Decision is non-binding, which means that candidates who receive offers of admission may choose from all medical school acceptances in line with AMCAS policy and medical school “Choose Your Medical School Tool” policies and deadlines.
• All Regular Decision applicants must present valid MCAT scores, apply through AMCAS by November 1, and have the secondary application (by invitation only) complete and verified to the Office of Admissions by Dec. 1 of the year before anticipated enrollment.
• Notification to the applicant regarding admission is given on a rolling basis. Generally, the first round of RDP acceptances are communicated in late January. RDP students may be accepted on a rolling admission basis through July.   For more about consideration of whether regular decision is right for you, visit students-residents.aamc.org.

M.D./Ph.D.  ADMISSION PLAN

Applicants interested in acceptance into a combined M.D./Ph.D. program may do so using AMCAS by selecting the M.D. / Ph.D. application plan. Using one application, candidates are applying to both of these NEOMED programs:

• Doctor of Medicine (M.D.) Program
• Doctor of Philosophy (Ph.D.) Basic and Translational Biomedicine (Research)

Faculty from both the M.D. program and Ph.D. programs will review and evaluate M.D. /Ph.D. candidates. Candidates may interview for both programs. Acceptance is contingent upon approval by both the M.D. and the Ph.D. admission committees.

For questions about the Doctor of Philosophy (Ph.D.) Basic and Translational Biomedicine (Research) please contact Dr. Matthew Smith,  Co-Director, Basic & Translational Biomedicine Graduate Program, Assistant Professor (Tenure Track), College of Graduate Studies.

GRADUATE STUDIES SPECIAL PROGRAM PLAN

Regular Decision Plan candidates on the alternate list at the end of the admission cycle may be offered a reserved M.D. seat in the next cycle. The graduate studies special program is offered by invitation only. Candidates granted pre-approval from the prior year’s M.D. applicant pool choosing to complete a NEOMED graduate studies master’s degree program in a gap year may apply through AMCAS using the “Other Special Program” admission plan.

NEOMED matriculated about 45 students through the GSP for each of the last two cycles. All eligible interested students were offered GSP inclusion for 2025 and 2026 and represented about 40% of NEOMED’s entering first-year class.

Application Eligibility Guidelines

All traditional admission candidates must:

• Possess at least a baccalaureate (four-year) degree from a U.S. regionally accredited college or university or a Canadian university prior to enrolling at NEOMED (applicants may be in their final year of progress toward a degree prior to graduation at the time of application).
• Be a U.S citizen/U.S. permanent resident (latter must submit documentation of status during application process). This requirement still applies to Canadian university students.

All candidates for admission to NEOMED as M.D. students are required to have successfully completed (C – or better) the following prerequisite courses prior to matriculation:

• Two semesters of Organic Chemistry and one lab
• Two semesters of Physics
• Two semesters of Biology
• One semester of Biochemistry

Entering students, regardless of plan, may benefit from the recommended courses below (determined by surveying students and faculty):

• Anatomy
• Calculus
• Cell Biology
• Composition/Writing
• Genetics
• Immunology
• Microbiology
• Molecular Biology
• Neuroscience
• Physiology
• Sociology
• Statistics

Competitive Academic Profile

The academic profile for the most recent entering MD class (all first-year students) in July 2026 was:

• Overall GPA: 3.64 – 3.94 (middle 50%)
• Overall GPA average: 3.75
•  BCPM (Biology, Chemistry, Physics, and Math) GPA: 3.60 – 3.90 (middle 50%)
• Overall BCPM GPA average: 3.69
• MCAT score: 508 – 514 (middle 50%)
• MCAT average: 511

Many candidates applying through the competitive regular decision plan benefit from reviewing the entering student cohort profile of regular decision applicants. Regular decision plan students comprise about 60% of NEOMED’s first-year medical school class: 115 regular decision students entered NEOMED in July 2026:

• Overall GPA: 3.59 – 3.94 (middle 50%)
• Overall GPA average: 3.75
•  BCPM (Biology, Chemistry, Physics, and Math) GPA: 3.45 – 3.92 (middle 50%)
• Overall BCPM GPA average: 3.68
• MCAT score: 510 – 516 (middle 50%)
• MCAT average: 513

Note: NEOMED entering student profile data also appears in the Medical Student Admission Report. MSAR data definitions are established by AAMC and automatically calculated for NEOMED by the AAMC using AMCAS applicant data. 

Where do NEOMED students come from?

Students apply to NEOMED using the American Medical College Application Service (AMCAS) application from across the United States. For most entering classes, about 80% of the entering students are Ohio residents, whether they attend college in Ohio or elsewhere. About 20% of our incoming M.D. class arrives in northeast Ohio from all over the country. NEOMED interviewed over 400 non-Ohio resident candidates in the 2025 – 2026 admission cycle! We encourage AMCAS applications from both Ohio and non-Ohio residents.

👉 Students from the most recent entering M.D. class joined us from: